Renal denervation fails to lower blood pressure in critical test

[riky]

Renal denervation fails to lower blood pressure in critical test

By Gene Emery and Bill Berkrot PROVIDENCE, RI/WASHINGTON (Reuters) - Patients treated by renal artery denervation were no more likely to see their blood pressure decline than those who received a fake therapy in a major clinical trial, calling into question a therapy used in more than 80 countries to treat hypertension that doesn't respond to drugs. The study was considered a key test of the intervention in which nerve connections between the heart and kidney were disrupted in an effort to lower blood pressure as prior trials did not include a blinded control group for efficacy comparison. Because earlier tests of the technique did not involve treating some patients with sham therapy, "placebo effect may well explain all or most of the blood pressure differences" in two key trials, known as SYMPLICITY HTM-1 and HTN-2. Boston Scientific Corp and St. Jude Medical Inc also make renal denervation equipment.

Source: You are not allowed to view links. Register or Login